SYSTEM, APPARATUS, AND METHOD FOR DENERVATING AN ARTERY
    91.
    发明申请
    SYSTEM, APPARATUS, AND METHOD FOR DENERVATING AN ARTERY 审中-公开
    系统,装置和方法,用于降解动物

    公开(公告)号:US20130158509A1

    公开(公告)日:2013-06-20

    申请号:US13329669

    申请日:2011-12-19

    Abstract: The present disclosed subject matter is directed to a less invasive surgical system, apparatus and method including a guidable catheter for providing electroporation therapy to a subject suffering from heart or kidney disease. The system includes an electrical generator and an apparatus for denervating an artery. The apparatus includes a catheter having a proximal end, a distal end, a first lumen with a first exit port, a second lumen having a second exit port. The apparatus also includes a first needle including a first electrode. The apparatus also includes a displacement mechanism engaged to the catheter near the proximal end such that the displacement mechanism controls the linear position and angular position of the catheter.

    Abstract translation: 本公开的主题涉及一种侵入性较小的手术系统,装置和方法,其包括用于向患有心脏或肾脏疾病的受试者提供电穿孔治疗的引导导管。 该系统包括发电机和用于去神经支配动脉的装置。 该装置包括具有近端,远端,具有第一出口的第一腔和具有第二出口的第二腔的导管。 所述装置还包括包括第一电极的第一针。 该装置还包括在近端附近与导管接合的移位机构,使得移位机构控制导管的线性位置和角位置。

    Methods and compositions for treating tissue using silk proteins
    92.
    发明授权
    Methods and compositions for treating tissue using silk proteins 有权
    使用丝蛋白处理组织的方法和组合物

    公开(公告)号:US08465772B2

    公开(公告)日:2013-06-18

    申请号:US13472324

    申请日:2012-05-15

    Abstract: Compositions for forming a self-reinforcing composite biomatrix, methods of manufacture and use therefore are herein disclosed. Kits including delivery devices suitable for delivering the compositions are also disclosed. In some embodiments, the composition can include at least three components. In one embodiment, a first component can include a first functionalized polymer, a second component can include a second functionalized polymer and a third component can include silk protein or constituents thereof. In some embodiments, the composition can include at least one cell type and/or at least one growth factor. In some embodiments, the composition can include a biologic encapsulated, suspended, disposed within or loaded into a biodegradable carrier. In some embodiments, the composition(s) of the present invention can be delivered by a dual lumen injection device to a treatment area in situ, in vivo, as well as ex vivo applications.

    Abstract translation: 本文公开了用于形成自增强复合生物基质的组合物,因此制造和使用方法。 还公开了包括适合递送组合物的递送装置的试剂盒。 在一些实施方案中,组合物可以包括至少三种组分。 在一个实施方案中,第一组分可以包括第一官能化聚合物,第二组分可以包括第二官能化聚合物,第三组分可以包括丝蛋白或其组分。 在一些实施方案中,组合物可以包括至少一种细胞类型和/或至少一种生长因子。 在一些实施方案中,组合物可以包括生物封装的,悬浮的,置于生物降解载体内或加载到可生物降解的载体中。 在一些实施方案中,本发明的组合物可以通过双腔注射装置原位,体内和离体应用递送至治疗区域。

    Methods and compositions for treating tissue using silk proteins
    93.
    发明授权
    Methods and compositions for treating tissue using silk proteins 有权
    使用丝蛋白处理组织的方法和组合物

    公开(公告)号:US08192760B2

    公开(公告)日:2012-06-05

    申请号:US11566643

    申请日:2006-12-04

    Abstract: Compositions for forming a self-reinforcing composite biomatrix, methods of manufacture and use therefore are herein disclosed. Kits including delivery devices suitable for delivering the compositions are also disclosed. In some embodiments, the composition can include at least three components. In one embodiment, a first component can include a first functionalized polymer, a second component can include a second functionalized polymer and a third component can include silk protein or constituents thereof. In some embodiments, the composition can include at least one cell type and/or at least one growth factor. In some embodiments, the composition can include a biologic encapsulated, suspended, disposed within or loaded into a biodegradable carrier. In some embodiments, the composition(s) of the present invention can be delivered by a dual lumen injection device to a treatment area in situ, in vivo, as well as ex vivo applications.

    Abstract translation: 本文公开了用于形成自增强复合生物基质的组合物,因此制造和使用方法。 还公开了包括适合递送组合物的递送装置的试剂盒。 在一些实施方案中,组合物可以包括至少三种组分。 在一个实施方案中,第一组分可以包括第一官能化聚合物,第二组分可以包括第二官能化聚合物,第三组分可以包括丝蛋白或其组分。 在一些实施方案中,组合物可以包括至少一种细胞类型和/或至少一种生长因子。 在一些实施方案中,组合物可以包括生物封装的,悬浮的,置于生物降解载体内或加载到可生物降解的载体中。 在一些实施方案中,本发明的组合物可以通过双腔注射装置原位,体内和离体应用递送至治疗区域。

    PLASTICIZERS FOR COATING COMPOSITIONS
    95.
    发明申请
    PLASTICIZERS FOR COATING COMPOSITIONS 有权
    涂料组合物增塑剂

    公开(公告)号:US20090238854A1

    公开(公告)日:2009-09-24

    申请号:US12475296

    申请日:2009-05-29

    Abstract: A biocompatible plasticizer useful for forming a coating composition with a biocompatible polymer is provided. The coating composition may also include a biobeneficial polymer and/or a bioactive agent. The coating composition can form a coating on an implantable device. The implantable device can be used to treat or prevent a disorder such as atherosclerosis, thrombosis, restenosis, hemorrhage, vascular dissection or perforation, vascular aneurysm, vulnerable plaque, chronic total occlusion, claudication, anastomotic proliferation for vein and artificial grafts, bile duct obstruction, ureter obstruction, tumor obstruction, or combinations thereof.

    Abstract translation: 提供了可用于形成具有生物相容性聚合物的涂料组合物的生物相容性增塑剂。 涂料组合物还可以包括生物有益的聚合物和/或生物活性剂。 涂料组合物可以在可植入装置上形成涂层。 可植入装置可用于治疗或预防动脉粥样硬化,血栓形成,再狭窄,出血,血管解剖或穿孔,血管动脉瘤,易损斑块,慢性完全闭塞,跛行,静脉和人造移植物的吻合增殖等障碍,胆管阻塞 ,输尿管阻塞,肿瘤阻塞或其组合。

    Methods and Compositions for Treating Tissue Using Silk Proteins
    96.
    发明申请
    Methods and Compositions for Treating Tissue Using Silk Proteins 有权
    使用丝蛋白处理组织的方法和组合物

    公开(公告)号:US20080131509A1

    公开(公告)日:2008-06-05

    申请号:US11566643

    申请日:2006-12-04

    Abstract: Compositions for forming a self-reinforcing composite biomatrix, methods of manufacture and use therefore are herein disclosed. Kits including delivery devices suitable for delivering the compositions are also disclosed. In some embodiments, the composition can include at least three components. In one embodiment, a first component can include a first functionalized polymer, a second component can include a second functionalized polymer and a third component can include silk protein or constituents thereof. In some embodiments, the composition can include at least one cell type and/or at least one growth factor. In some embodiments, the composition can include a biologic encapsulated, suspended, disposed within or loaded into a biodegradable carrier. In some embodiments, the composition(s) of the present invention can be delivered by a dual lumen injection device to a treatment area in situ, in vivo, as well as ex vivo applications.

    Abstract translation: 本文公开了用于形成自增强复合生物基质的组合物,因此制造和使用方法。 还公开了包括适合递送组合物的递送装置的试剂盒。 在一些实施方案中,组合物可以包括至少三种组分。 在一个实施方案中,第一组分可以包括第一官能化聚合物,第二组分可以包括第二官能化聚合物,第三组分可以包括丝蛋白或其组分。 在一些实施方案中,组合物可以包括至少一种细胞类型和/或至少一种生长因子。 在一些实施方案中,组合物可以包括生物封装的,悬浮的,置于生物降解载体内或加载到可生物降解的载体中。 在一些实施方案中,本发明的组合物可以通过双腔注射装置原位,体内和离体应用递送至治疗区域。

    DEVICE AND METHOD FOR COMBINING A TREATMENT AGENT AND A GEL
    97.
    发明申请
    DEVICE AND METHOD FOR COMBINING A TREATMENT AGENT AND A GEL 有权
    用于组合治疗剂和凝胶的装置和方法

    公开(公告)号:US20080114293A1

    公开(公告)日:2008-05-15

    申请号:US12013286

    申请日:2008-01-11

    CPC classification number: A61K9/0024 A61K9/06

    Abstract: A method including introducing a treatment agent at a treatment site within a mammalian host; and introducing a bioerodable gel material at the treatment site. An apparatus including a first annular member having a first lumen disposed about a length of the first annular member and a first entry port at a proximal end of the first annular member, and a second annular member coupled to the first annular member having a second lumen disposed about a length of the second annular member and a second entry port at a proximal end of the second annular member, wherein the first annular member and the second annular member are positioned to allow a combining of treatment agents introduced through each annular member at the treatment site.

    Abstract translation: 一种方法,包括在哺乳动物宿主内的处理部位引入处理剂; 并在处理部位引入可生物浸渍的凝胶材料。 一种包括第一环形构件的装置,所述第一环形构件具有围绕所述第一环形构件的长度设置的第一腔和在所述第一环形构件的近端处的第一入口,以及联接到所述第一环形构件的第二环形构件,所述第二环形构件具有第二内腔 设置在所述第二环形构件的大约一定长度处和在所述第二环形构件的近端处的第二入口,其中所述第一环形构件和所述第二环形构件被定位成允许通过每个环形构件引入的处理剂在 治疗部位。

Patent Agency Ranking